MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
MNMD Mind Medicine
- 7.1600
- +0.1450+2.07%
Close Dec 20 16:00 ET
- 7.1600
- 0.00000.00%
Post 20:01 ET
525.05MMarket Cap-4.19P/E (TTM)
7.3550High6.9225Low1.77MVolume6.9600Open7.0150Pre Close12.65MTurnover3.31%Turnover RatioLossP/E (Static)73.33MShares12.220052wk High2.00P/B382.59MFloat Cap3.490052wk Low--Dividend TTM53.43MShs Float86.5500Historical High--Div YieldTTM6.17%Amplitude2.1200Historical Low7.1530Avg Price1Lot Size
About Mind Medicine Company
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
Company Profile
SymbolMNMD
Company NameMind Medicine
Founded2010
CEOMr. Robert B. Barrow
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
AddressOne World Trade Center,Suite 8500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10007
Phone1-212-220-6633
Websitehttp://www.mindmed.co
Company Executives
- Name
- Position
- Salary
- Robert B. Barrow
- Chief Executive Officer and Director
- 2.14M
- Carrie F. Liao
- Chief Accounting Officer
- --
- Schond L. Greenway
- Chief Financial Officer
- 1.14M
- Mark R. Sullivan, J.D.
- Chief Legal Officer and Corporate Secretary
- --
- Dr. Daniel R. Karlin, M.A.,M.D.
- Chief Medical Officer
- 1.04M
- Dr. Miri Halperin Wernli, PhD
- Executive President
- --
- Andreas Krebs
- Vice Chairman of the Board
- 186.20K
- Carol A. Vallone
- Chairman of the Board
- 196.20K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 148.70K
- Dr. Roger Crystal, M.D.
- Independent Director
- 148.70K
- David W. Gryska, M.B.A.
- Independent Director
- 179.01K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.